Recently, immunohistochemistry studies have been implemented to differentiate the two types of lesions: the Mindbomb Homolog-1 (MIB-1) proliferation marker, for example, has a nuclear proliferation index of 1.5% in Spitz nevus compared to 14.9% in Spitz melanoma (1). The gene discussed is MIB1; the disease is spitz nevus.